Explore approved biosimilar medicines
| # | Medicine | Status | Active Substance | Therapeutic Area | Developer | Published Date |
|---|---|---|---|---|---|---|
| 71 | Hefiya | Authorised | adalimumab | Spondylitis, Ankylosing;Hidradenitis Suppurativa;Psoriasis;Arthritis, Juvenile Rheumatoid;Uveitis | Sandoz GmbH | 26-07-2018 |
| 72 | Bildyos | Authorised | denosumab | Bone Resorption;Osteoporosis, Postmenopausal;Osteoporosis | Sciencepharma Sp. z o.o | 25-07-2025 |
| 73 | Alymsys | Authorised | bevacizumab | Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | Mabxience Research SL | 26-04-2021 |
| 74 | Insulin aspart Sanofi | Authorised | insulin aspart | Diabetes Mellitus | Sanofi Winthrop Industrie | 07-07-2020 |
| 75 | Yuflyma | Authorised | adalimumab | Arthritis, Rheumatoid;Arthritis, Psoriatic;Psoriasis;Spondylitis, Ankylosing;Uveitis;Hidradenitis Suppurativa;Colitis, Ulcerative;Crohn Disease;Arthritis, Juvenile Rheumatoid | Celltrion Healthcare Hungary Kft. | 26-02-2021 |
| 76 | Avzivi | Authorised | bevacizumab | Colorectal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Uterine Cervical Neoplasms | FGK Representative Service GmbH | 08-08-2024 |
| 77 | Tocilizumab STADA (previously Tofidence) | Authorised | tocilizumab | Arthritis, Rheumatoid;COVID-19 virus infection;Arthritis, Juvenile Rheumatoid | STADA Arzneimittel AG | 10-07-2024 |
| 78 | Imraldi | Authorised | adalimumab | Spondylitis, Ankylosing;Arthritis, Rheumatoid;Uveitis;Colitis, Ulcerative;Psoriasis;Arthritis, Psoriatic;Crohn Disease;Hidradenitis Suppurativa;Arthritis | Samsung Bioepis NL B.V. | 12-07-2018 |
| 79 | Trazimera | Authorised | trastuzumab | Stomach Neoplasms;Breast Neoplasms | Pfizer Europe MA EEIG | 14-09-2018 |
| 80 | Insulin lispro Sanofi | Authorised | insulin lispro | Diabetes Mellitus | Sanofi Winthrop Industrie | 03-04-2018 |
Ready to transform your strategic intelligence? Let's talk
Get latest pharmaceutical insights, blogs, and strategic updates directly in your inbox.